VILNIUS, July 7 (Xinhua) -- Lithuania plans to buy the antiviral drug remdesivir for the treatment of patients infected with COVID-19, the Health Ministry announced on Tuesday.
Lithuania needs more than 2,400 ampoules of remdesivir and now seeks to purchase slightly more than 700 ampoules, said the ministry in a release.
Part of the planned amount will be purchased together with other European Union countries while the remaining will be bought individually.
According to the ministry, remdesivir is recommended for the treatment of COVID-19 in adults and adolescents aged 12 or older with pneumonia requiring supplemental oxygen.
Lithuania made the decision to buy remdesivir after the European Commission gave the greenlight to remdesivir last week.
The European Commission authorized remdesivir for the treatment against coronavirus on Friday, making it the first drug authorized at the European Union level for the treatment of COVID-19. Enditem
